Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Operating Profit

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Operating Profit (Excl OI) ₹2,194 Cr₹1,751 Cr₹912 Cr₹264 Cr₹604 Cr

What is the latest Operating Profit of NATCO PHARMA ?

The latest Operating Profit ratio of NATCO PHARMA is ₹2,194 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹2,194 Cr
Mar2024₹1,751 Cr
Mar2023₹912 Cr
Mar2022₹264 Cr
Mar2021₹604 Cr

How is Operating Profit of NATCO PHARMA Trending?

Years Operating Profit % Change
Mar2025 ₹2,194 Cr
25.26
Mar2024 ₹1,751 Cr
92.10
Mar2023 ₹912 Cr
246.00
Mar2022 ₹264 Cr
-56.36
Mar2021 ₹604 Cr -

Compare Operating Profit of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,079.6 Cr -1.9% -5.6% -1.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹450,211.0 Cr -3% -4.1% 16.7% Stock Analytics
DIVIS LABORATORIES ₹228,303.0 Cr 0.6% 17.5% 41.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.7% -0.6% 35.5% Stock Analytics
CIPLA ₹115,672.0 Cr -2% -0.7% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹98,533.5 Cr -1.5% -3.5% -2.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.9%

-5.6%

-1.1%

SENSEX

-1.2%

-1.2%

-3.3%


You may also like the below Video Courses